Matteo Toma, Giulio Savonitto, Carlo Maria Lombardi, Edoardo Airò, Mauro Driussi, Piero Gentile, Luke Howard, Martina Moschella, Emma Di Poi, Matteo Pagnesi, Simonetta Monti, Valentino Collini, Luciana D'Angelo, Veronica Vecchiato, Alberto Giannoni, Marianna Adamo, Davide Barbisan, Carolina Bauleo, Andrea Garascia, Marco Metra, Gianfranco Sinagra, Francesco Lo Giudice, Davide Stolfo, Pietro Ameri
AIM: To obtain real-world evidence about the features and risk stratification of pulmonary arterial hypertension (PAH) with a left heart disease (LHD) phenotype (PAH-LHD). METHODS AND RESULTS: By reviewing the records of consecutive incident PAH patients at 7 tertiary centers from 2001 to 2021, we selected 286 subjects with all parameters needed to determine risk of death at baseline and at first follow-up with COMPERA and COMPERA 2.0 scores. Fifty seven (20%) had PAH-LHD according to the AMBITION definition...
April 15, 2024: Clinical Research in Cardiology: Official Journal of the German Cardiac Society